key: cord-0704530-yfgdjzcr
authors: Mateeva, Valeria; Vassileva, Snejina
title: Impact of COVID-19 pandemic on the management of cutaneous lymphomas
date: 2020-09-07
journal: Clin Dermatol
DOI: 10.1016/j.clindermatol.2020.09.002
sha: 7f833ed60e3d11d30ef76bbc071f2b28724987a8
doc_id: 704530
cord_uid: yfgdjzcr

nan

she underwent successful local radiation therapy (25 Gy in five fractions) with satisfactory effect (Fig. 2b) . In May 2020, the disease rapidly worsened with the appearance of multiple new tumor lesions suggestive of large cell transformation of MF (Fig. 2c) . Due to the national emergency state, admission to the hematology department for re-staging and systemic therapy was postponed by two months.

The COVID-19 outbreak may put patients with cutaneous lymphomas at additional risk of not receiving the necessary diagnostic procedures and treatment because they can not access easily hospitals or due to limitation of healthcare resources. Several guidelines for management of cutaneous lymphoma have been recently published to help dermatologists choosing the right approach in PCL management throughout COVID-19 pandemic. 3 , 4 , 5 .

However, it occurs that guidelines are not applicable, in individual country cases of complete lockdown. We would like to draw attention to the indirect damage that the COVID-19 is causing to the public health, where diagnosis and relevant treatment of manageable diseases is delayed, thus causing potential disease worsening, even death. According to our experience, these unmet medical needs concern both patients with low-grade MF and those with more aggressive clinical course. 

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium

United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic

ILROG emergency guidelines for radiation therapy